Article Details
Retrieved on: 2020-12-21 15:47:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The group's competitors in haemophilia B include Roche, whose fidanacogene elaparvovec, gained through the acquisition of Spark, is partnered with ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here